{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:38:49Z","timestamp":1792834729775,"version":"4.5.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"the Internal Research Fund of Huadu District People\u2019s Hospital of Guangzhou","award":["2022C07"],"award-info":[{"award-number":["2022C07"]}]},{"name":"the Construction of Major Subject of Huadu District People\u2019s Hospital of Guangzhou","award":["YNZDXK202501"],"award-info":[{"award-number":["YNZDXK202501"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,28]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>This study aims to assess the impact of low-dose flurbiprofen axetil on the incidence of perioperative acute kidney injury (AKI) in patients undergoing percutaneous nephrolithotomy (PCNL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Between February and July 2025, 130 patients undergoing PCNL under general anesthesia at Huadu District People\u2019s Hospital of Guangzhou were enrolled and randomly allocated to either the control group (Group C, n\u2005=\u200565) or the flurbiprofen group (Group FA, n\u2005=\u200565). Following surgery, patients in Group FA received 100\u2009mg of flurbiprofen axetil intravenously, while Group C received 10\u2009ml of normal saline. Serum creatinine, glomerular filtration rate (GFR), cystatin C, and neutrophil gelatinase-associated lipocalin (NGAL) levels were measured preoperatively and at 6, 24, and 48 hours postoperatively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 120 patients completed the study (Group C, n\u2005=\u200560; Group FA, n\u2005=\u200560). Baseline characteristics were comparable between the 2 groups (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&gt;\u2005.05). Five cases of AKI were observed in Group C, compared to one in Group FA, with no statistically significant difference (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.207). At 6 hours postoperatively, NGAL levels in Group C were significantly higher than in Group FA (216.35\u2005\u00b1\u200563.39 vs 184.84\u2005\u00b1\u200543.14,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.002). No significant differences were found in serum creatinine, NGAL, or cystatin C levels at other time points.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Postoperative administration of 100\u2009mg flurbiprofen axetil may reduce NGAL levels at 6 hours after PCNL, indicating a potential protective effect on renal function.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050384","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:00:06Z","timestamp":1787968806000},"page":"e50384","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Effects of flurbiprofen axetil on postoperative renal function in patients undergoing percutaneous nephrolithotomy"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5462-4589","authenticated-orcid":false,"given":"Dong","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Huadu District People\u2019s Hospital of Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Huadu District People\u2019s Hospital of Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Huadu District People\u2019s Hospital of Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixia","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, Huadu District People\u2019s Hospital of Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Lu","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Hematologic Diseases, Cyrus Tang Medical Institute, Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Prevention, Soochow University, Suzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxin","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Huadu District People\u2019s Hospital of Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyuan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Huadu District People\u2019s Hospital of Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Huadu District People\u2019s Hospital of Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Huadu District People\u2019s Hospital of Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261024","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.294.7.813","article-title":"Acute renal failure in critically ill patients: a multinational, multicenter study.","volume":"294","author":"Uchino","year":"2005","journal-title":"JAMA"},{"key":"R2-20261024","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s11255-018-1828-7","article-title":"Epidemiological characteristics of and risk factors for patients with postoperative acute kidney injury: a multicenter prospective study in 30 Chinese intensive care units.","volume":"50","author":"Zhang","year":"2018","journal-title":"Int Urol Nephrol"},{"key":"R3-20261024","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0140-6736(17)31329-6","article-title":"Management of patients at risk of acute kidney injury.","volume":"389","author":"Vanmassenhove","year":"2017","journal-title":"Lancet"},{"key":"R4-20261024","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/S0140-6736(15)60126-X","article-title":"International Society of Nephrology\u2019s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology.","volume":"385","author":"Mehta","year":"2015","journal-title":"Lancet"},{"key":"R5-20261024","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury.","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"R6-20261024","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s13054-016-1478-z","article-title":"Acute kidney injury 2016: diagnosis and diagnostic workup.","volume":"20","author":"Ostermann","year":"2016","journal-title":"Crit Care"},{"key":"R7-20261024","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.eururo.2015.07.041","article-title":"EAU guidelines on interventional treatment for urolithiasis.","volume":"69","author":"Turk","year":"2016","journal-title":"Eur Urol"},{"key":"R8-20261024","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4103\/jrms.jrms_317_23","article-title":"Prevalence of acute kidney injury following percutaneous nephrolithotomy.","volume":"29","author":"Paymannejad","year":"2024","journal-title":"J Res Med Sci"},{"key":"R9-20261024","doi-asserted-by":"crossref","first-page":"955","DOI":"10.5812\/numonthly.12721","article-title":"Acute kidney injury in urology patients: incidence, causes and outcomes.","volume":"5","author":"Caddeo","year":"2013","journal-title":"Nephrourol Mon"},{"key":"R10-20261024","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3390\/jcm10071373","article-title":"Acute kidney injury post-percutaneous nephrolithotomy (PNL): prospective outcomes from a University Teaching Hospital.","volume":"10","author":"Pillai","year":"2021","journal-title":"J Clin Med"},{"key":"R11-20261024","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00345-021-03874-4","article-title":"Acute kidney injury and percutaneous nephrolithotomy: incidence and predictive factors.","volume":"40","author":"Fulla","year":"2022","journal-title":"World J Urol"},{"key":"R12-20261024","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s00540-017-2409-0","article-title":"Preoperative flurbiprofen axetil administration for acute postoperative pain: a meta-analysis of randomized controlled trials.","volume":"31","author":"Wang","year":"2017","journal-title":"J Anesth"},{"key":"R13-20261024","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1177\/106002809102500731","article-title":"Renal papillary necrosis induced by flurbiprofen.","volume":"25","author":"Colome Nafria","year":"1991","journal-title":"DICP"},{"key":"R14-20261024","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000168291","article-title":"Flurbiprofen-associated acute tubulointerstitial nephritis.","volume":"11","author":"Kaufhold","year":"1991","journal-title":"Am J Nephrol"},{"key":"R15-20261024","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fped.2019.00520","article-title":"The invisible threat of non-steroidal anti-inflammatory drugs for kidneys.","volume":"7","author":"Clav\u00e9","year":"2019","journal-title":"Front Pediatr"},{"key":"R16-20261024","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejim.2022.05.003","article-title":"Acute kidney injury associated with non-steroidal anti-inflammatory drugs.","volume":"101","author":"Klomjit","year":"2022","journal-title":"Eur J Intern Med"},{"key":"R17-20261024","doi-asserted-by":"crossref","first-page":"e047840","DOI":"10.1136\/bmjopen-2020-047840","article-title":"Correlation between perioperative parecoxib use and postoperative acute kidney injury in patients undergoing non-cardiac surgery: a retrospective cohort analysis.","volume":"11","author":"Tang","year":"2021","journal-title":"BMJ Open"},{"key":"R18-20261024","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12871-022-01688-4","article-title":"Correlation between perioperative parecoxib use and postoperative acute kidney injury in patients undergoing radical mastectomy: a retrospective cohort analysis.","volume":"22","author":"Xu","year":"2022","journal-title":"BMC Anesthesiol"},{"key":"R19-20261024","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12882-020-1711-5","article-title":"Low dose of flurbiprofen axetil decrease the rate of acute kidney injury after operation: a retrospective clinical data analysis of 9915 cases.","volume":"21","author":"Wang","year":"2020","journal-title":"BMC Nephrol"},{"key":"R20-20261024","first-page":"1","article-title":"Perioperative use of flurbiprofen axetil on renal function after transurethral prostatectomy: a prospective randomized controlled study.","volume":"2021","author":"Wang","year":"2021","journal-title":"J Nanomater"},{"key":"R21-20261024","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"R22-20261024","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/SLA.0000000000004314","article-title":"Perioperative Nonsteroidal Anti-inflammatory Drugs (NSAID) Administration and Acute Kidney Injury (AKI) in major gastrointestinal surgery: a prospective, multicenter, propensity matched cohort study.","volume":"275","year":"2022","journal-title":"Ann Surg"},{"key":"R23-20261024","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jtcvs.2019.08.119","article-title":"Association between preoperative aspirin and acute kidney injury following coronary artery bypass grafting.","volume":"160","author":"Aboul-Hassan","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R24-20261024","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000313738","article-title":"Pathophysiology of AKI: injury and normal and abnormal repair.","volume":"165","author":"Bonventre","year":"2010","journal-title":"Contrib Nephrol"},{"key":"R25-20261024","doi-asserted-by":"crossref","first-page":"100889","DOI":"10.1016\/j.mam.2020.100889","article-title":"The NLRP3 inflammasome: mechanism of action, role in disease and therapies.","volume":"76","author":"Wang","year":"2020","journal-title":"Mol Aspects Med"},{"key":"R26-20261024","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3389\/fcell.2019.00379","article-title":"Effect and regulation of the NLRP3 inflammasome during renal fibrosis.","volume":"7","author":"Zhang","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"R27-20261024","doi-asserted-by":"crossref","first-page":"e0166707","DOI":"10.1371\/journal.pone.0166707","article-title":"Expression and function of interleukin-1\u03b2-induced neutrophil gelatinase-associated lipocalin in renal tubular cells.","volume":"11","author":"Konno","year":"2016","journal-title":"PLoS One"},{"key":"R28-20261024","first-page":"8375746","article-title":"Effects of a single dose of parecoxib on inflammatory response and ischemic tubular injury caused by hemorrhagic shock in rats.","volume":"2018","author":"Takaku","year":"2018","journal-title":"Pain Res Treat"},{"key":"R29-20261024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1874467210902010001","article-title":"Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition.","volume":"2","author":"Hamza","year":"2009","journal-title":"Curr Mol Pharmacol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050384","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:01:50Z","timestamp":1792832510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050384"}},"subtitle":["A prospective, randomized, double-blind, controlled clinical study"],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":29,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050384","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"2025-07-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}